Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DCare K2 is a nutraceutical combination of Vitamin D3 (cholecalciferol) and Vitamin K2 (menaquinone-7, MK-7) developed by Procare Health. It is designed to support bone health, immune function, and cardiovascular health, particularly in individuals with vitamin D deficiency or menopausal women. Vitamin D3 facilitates calcium absorption and maintains bone density and muscle function, while Vitamin K2 (as MK-7) regulates osteocalcin and modulates osteoclast/osteoblast activity to promote bone formation and prevent arterial calcification. The product is formulated in virgin olive oil to enhance absorption and is available as a daily oral capsule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cholecalciferol + menaquinone-7.